217 related articles for article (PubMed ID: 21896903)
1. Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1.
Brown NG; Horton LB; Huang W; Vongpunsawad S; Palzkill T
Antimicrob Agents Chemother; 2011 Dec; 55(12):5696-702. PubMed ID: 21896903
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.
Horton LB; Shanker S; Mikulski R; Brown NG; Phillips KJ; Lykissa E; Venkataram Prasad BV; Palzkill T
Antimicrob Agents Chemother; 2012 Nov; 56(11):5667-77. PubMed ID: 22908171
[TBL] [Abstract][Full Text] [Related]
4. Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis.
Brown NG; Shanker S; Prasad BV; Palzkill T
J Biol Chem; 2009 Nov; 284(48):33703-12. PubMed ID: 19812041
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of the active site of a metallo-beta-lactamase proliferating in Japan.
Haruta S; Yamaguchi H; Yamamoto ET; Eriguchi Y; Nukaga M; O'Hara K; Sawai T
Antimicrob Agents Chemother; 2000 Sep; 44(9):2304-9. PubMed ID: 10952572
[TBL] [Abstract][Full Text] [Related]
6. Amino acid sequence requirements at residues 69 and 238 for the SME-1 beta-lactamase to confer resistance to beta-lactam antibiotics.
Majiduddin FK; Palzkill T
Antimicrob Agents Chemother; 2003 Mar; 47(3):1062-7. PubMed ID: 12604542
[TBL] [Abstract][Full Text] [Related]
7.
Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
[TBL] [Abstract][Full Text] [Related]
8. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
9. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the context dependent sequence requirements of active site residues in the metallo-beta-lactamase IMP-1.
Materon IC; Beharry Z; Huang W; Perez C; Palzkill T
J Mol Biol; 2004 Nov; 344(3):653-63. PubMed ID: 15533435
[TBL] [Abstract][Full Text] [Related]
11. Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
Li M; Conklin BC; Taracila MA; Hutton RA; Skalweit MJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5678-86. PubMed ID: 22908166
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the active-site residues asparagine 167 and lysine 161 of the IMP-1 metallo beta-lactamase.
Haruta S; Yamamoto ET; Eriguchi Y; Sawai T
FEMS Microbiol Lett; 2001 Apr; 197(1):85-9. PubMed ID: 11287151
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene.
Vakulenko SB; Geryk B; Kotra LP; Mobashery S; Lerner SA
Antimicrob Agents Chemother; 1998 Jul; 42(7):1542-8. PubMed ID: 9660980
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the role of Trp105 in the KPC-2 β-lactamase.
Papp-Wallace KM; Taracila M; Wallace CJ; Hujer KM; Bethel CR; Hornick JM; Bonomo RA
Protein Sci; 2010 Sep; 19(9):1714-27. PubMed ID: 20662006
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
Borgianni L; Vandenameele J; Matagne A; Bini L; Bonomo RA; Frère JM; Rossolini GM; Docquier JD
Antimicrob Agents Chemother; 2010 Aug; 54(8):3197-204. PubMed ID: 20498317
[TBL] [Abstract][Full Text] [Related]
16. Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.
Carenbauer AL; Garrity JD; Periyannan G; Yates RB; Crowder MW
BMC Biochem; 2002; 3():4. PubMed ID: 11876827
[TBL] [Abstract][Full Text] [Related]
17. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
[TBL] [Abstract][Full Text] [Related]
18. E152A substitution drastically affects NDM-5 activity.
Kumar G; Issa B; Kar D; Biswal S; Ghosh AS
FEMS Microbiol Lett; 2017 Feb; 364(3):. PubMed ID: 28087620
[TBL] [Abstract][Full Text] [Related]
19. Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group.
de Souza J; Vieira AZ; Dos Santos HG; Faoro H
BMC Genomics; 2024 May; 25(1):508. PubMed ID: 38778284
[TBL] [Abstract][Full Text] [Related]
20. SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Papagiannitsis CC; Loli A; Tzouvelekis LS; Tzelepi E; Arlet G; Miriagou V
Antimicrob Agents Chemother; 2007 Jun; 51(6):2185-8. PubMed ID: 17353248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
